Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like peptide

Obesity Research

Volumn 13, Issue 6, 2005, Pages 1000-1007

  Cam, Patrice D ^a   Neyrinck, Audrey M ^a   Maton, Nicole ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Anorexigenic; Fructans; Ghrelin; Gut peptides; Orexigenic

Indexed keywords

RATTUS NORVEGICUS;

DIPEPTIDYL PEPTIDASE IV; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; MESSENGER RNA; OLIGOFRUCTOSE; OLIGOSACCHARIDE; PEPTIDE; PEPTIDE FRAGMENT; PEPTIDE HORMONE; PROGLUCAGON; PROTEIN PRECURSOR; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; DRUG EFFECT; EATING; FAT INTAKE; GENETICS; INTESTINE; INTESTINE MUCOSA; LIVER; MALE; METABOLISM; OBESITY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; WISTAR RAT;

ANIMALS; ANTIGENS, CD26; BODY WEIGHT; DIETARY FATS; EATING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; INTESTINAL MUCOSA; INTESTINES; LIVER; MALE; OBESITY; OLIGOSACCHARIDES; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PEPTIDES; PROGLUCAGON; PROTEIN PRECURSORS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

EID: 26944502419     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.117     Document Type: Article

References (45)

1. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res. 1990:31:1149-72.
2. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr. 1998;68:1157-73.
3. West DB, York B. Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am J Clin Nutr. 1998; 67:505-128.
4. Lucas F, Sclafani A. Differential reinforcing and satiating effects of intragastric fat and carbohydrate infusions in rats. Physiol Behav. 1999:66:381-8.
5. Blundell JE, Macdiarmid JI. Passive overconsumption. Fat intake and short-term energy balance. Ann N Y Acad Sci. 1997:827:392-407.
6. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr. 2000:130:1314-9.
7. Delzenne NM, Williams CM. Prebiotics and lipid metabolism. Curr Opin Lipidol. 2002;13:61-7.
8. Delzenne NM. Oligosaccharides: state of the art. Proc Nutr Soc. 2003;62:177-82.
9. Kok NN, Taper HS, Delzenne NM. Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol. 1998;18:47-53.
10. Daubioul C, Rousseau N, Demeure R, et al. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr. 2002;132:967-73.
11. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation, glucagon-like peptide-1. and ghrelin. in rats. Br J Nutr. 2004:92:521-6.
12. Orskov C, Bersani M, Johnsen AH, Hojrup P, Holst JJ. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem. 1989:264:12826-9.
13. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515-20.
14. Naslund E, Barkeling B, King N, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 1999:23:304-11.
15. Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. Glucagonlike peptide l as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol. 2002;440:269-79.
16. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824-30.
17. Brubaker PL, Drucker DJ. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology. 2004; 145: 2653-9.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60.
19. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-13.
20. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-61.
21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9.
23. Sullivan AC, Triscari J, Cornai K. Caloric compensatory responses to diets containing either nonabsorbable carbohydrate or lipid by obese and lean Zucker rats. Am J Clin Nutr. 1978;31:S261-6.
24. Ramirez I, Friedman MI. Dietary hyperphagia in rats: role of fat, carbohydrate, and energy content. Physiol Behav. 1990; 47:1157-63.
25. Delzenne NM, Cani PD, Daubioul C, Neyrinck A. Impact of inulin and oligofructose on gluco-incretins. Br J Nutr. 2005; (in press).
26. Delzenne NM, Kok N, Deloyer P, Dandrifosse G. Dietary fructans modulate polyamine concentration in the cecum of rats. J Nutr. 2000;130:2456-60.
27. Philippe J, Drucker DJ, Chick WL, Habener JF. Transcriptional regulation of genes encoding insulin, glucagon, and angiotensinogen by sodium butyrate in a rat islet cell line. Mol Cell Biol. 1987;7:560-3.
28. Le Blay G, Michel C, Blottiere HM, Cherbut C. Enhancement of butyrate production in the rat caecocolonic tract by long-term ingestion of resistant potato starch. Br J Nutr. 1999;82:419-26.
29. Burcelin R, Da Costa A, Drucker D, Thorens B: Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes. 2001:50:1720-8.
30. Druce MR, Small CJ, Bloom SR. Gut peptides regulating satiety. Endocrinology. 2004:145:2660-5.
31. Drucker DJ, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol. 1997;15:673-977.
32. Wojdemann M, Wettergren A, Hartmann B, Holst JJ. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol. 1998;33:828-32.
33. Nagell CF, Wettergren A, Pedersen JF, Mortensen D, Holst JJ. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scand J Gastroenterol. 2004;39:353-8.
34. Wojdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab. 1999;84:2513-7.
35. Kok NN, Morgan LM, Williams CM, Roberfroid MB, Thissen JP, Delzenne NM. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative of the hypolipidemic effect of oligofructose in rats. J Nutr. 1998;128:1099-103.
36. Meier JJ, Goetze O, Anstipp J, et al. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab. 2004;286:E621-5.
37. Rocca AS, Brubacker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology. 1999; 140:1687-94.
38. Djurhuus CB, Hansen TK, Gravholt C, et al. Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Metab Res. 2002;34:411-3.
39. Lippl F, Kircher F, Erdmann J, Allescher HD, Schusdziarra V. Effect of GIF, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul Pept. 2004; 119: 93-8.
40. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-9.
41. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 2002; 143:185-90.
42. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery. 1980;88:93-100.
43. Liu CH, Huang MT, Huang PC. Sources of triacylglycerol accumulation in livers of rats fed a cholesterol-supplemented diet. Lipids. 1995;30:527-31.
44. Fiordaliso M, Kok N, Desager JP, et al. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids. 1995; 30:163-7.
45. Kok N, Roberfroid M, Robert A, Delzenne N. Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr. 1996;76:881-90.